Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Puma Biotechnology (PBYI) Treasury Shares: 2017-2025

Historic Treasury Shares for Puma Biotechnology (PBYI) over the last 9 years, with Sep 2025 value amounting to $1.4 million.

  • Puma Biotechnology's Treasury Shares fell 0.47% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 0.47%. This contributed to the annual value of $1.3 million for FY2024, which is 20.65% down from last year.
  • Per Puma Biotechnology's latest filing, its Treasury Shares stood at $1.4 million for Q3 2025, which was down 25.07% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, Puma Biotechnology's Treasury Shares peaked at $2.5 million during Q1 2021, and registered a low of $1.3 million during Q4 2024.
  • Its 3-year average for Treasury Shares is $1.8 million, with a median of $1.8 million in 2025.
  • As far as peak fluctuations go, Puma Biotechnology's Treasury Shares decreased by 24.53% in 2021, and later grew by 24.33% in 2023.
  • Puma Biotechnology's Treasury Shares (Quarterly) stood at $1.4 million in 2021, then grew by 7.32% to $1.5 million in 2022, then increased by 8.20% to $1.6 million in 2023, then declined by 20.65% to $1.3 million in 2024, then dropped by 0.47% to $1.4 million in 2025.
  • Its Treasury Shares stands at $1.4 million for Q3 2025, versus $1.8 million for Q2 2025 and $1.9 million for Q1 2025.